ESCMID 2025
Vienna, AT, 11 - 15 Apr 2025
Join leading experts, discover cutting-edge research, and network with peers in a dynamic setting at ESCMID 2025 in Vienna. ESCMID brings together experts to discuss latest topics and recent advances in infectious diseases and clinical microbiology.
If you are interested in learning more about the work Owlstone Medical is doing, please get in touch to meet with us at the conference.
Meet the Team:
Dr Ben Constant
Dr Ben Constant is a Business Development Executive at Owlstone Medical, where he is dedicated to advancing breath biomarker research.
Ben completed his undergraduate studies in Biomedical Sciences at the University of Sheffield, before pursuing a PhD at the University of Cambridge under the supervision of Dr Wei Li in the Department of Medicine. His doctoral research focused on elucidating the mechanisms of action of a novel pharmaceutical treatment for obesity.
Ben has a diverse background in the medical technology sector. He previously worked at Ortho Clinical Diagnostics, where he contributed to the development of a diagnostic test for heart attacks. Additionally, he has served as a technical consultant, assisting MedTech innovators in bringing their cutting-edge technologies to market.
In his current role, Ben is passionate about collaborating with leading scientists across Europe and Asia, helping them explore how breath biomarkers can enhance their research and clinical outcomes.